Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: J Am Med Dir Assoc. 2016 May 6;17(6):553–556. doi: 10.1016/j.jamda.2016.03.002

Impact of a Videoconference Educational Intervention on Physical Restraint and Antipsychotic Use in Nursing Homes: Results From the ECHO-AGE Pilot Study

Stephen E Gordon a,b,c,*, Alyssa B Dufour a,c,d, Sara M Monti a, Melissa LP Mattison a,c, Angela G Catic a, Cindy P Thomas e, Lewis A Lipsitz a,c,d
PMCID: PMC5331906  NIHMSID: NIHMS849501  PMID: 27161317

Abstract

Objectives

US nursing homes care for increasing numbers of residents with dementia and associated behavioral problems. They often lack access to specialized clinical expertise relevant to managing these problems. Project ECHO-AGE provides this expertise through videoconference sessions between frontline nursing home staff and clinical experts at an academic medical center. We hypothesized that ECHO-AGE would result in less use of physical and chemical restraints and other quality improvements in participating facilities.

Design

A 2:1 matched-cohort study comparing quality of care outcomes between ECHO-AGE facilities and matched controls for the period July 2012 to December 2013.

Setting

Eleven nursing homes in Massachusetts and Maine.

Participants

Nursing home staff and a hospital-based team of geriatrician, geropsychiatrist, and neurologist discussed anonymized residents with dementia.

Intervention

Biweekly online video case discussions and brief didactic sessions focused on the management of dementia and behavior disorders.

Measurements

The primary outcome variables were percentage of residents receiving antipsychotic medications and the percentage of residents who were physically restrained. Secondary outcomes included 9 other quality of care metrics from MDS 3.0.

Results

Residents in ECHO-AGE facilities were 75% less likely to be physically restrained compared with residents in control facilities over the 18-month intervention period (OR = 0.25, P = .05). Residents in ECHO-AGE facilities were 17% less likely to be prescribed antipsychotic medication compared with residents in control facilities (OR = 0.83, P = .07). Other outcomes were not significantly different.

Conclusion

Preliminary evidence suggests that participation in Project ECHO-AGE reduces rates of physical restraint use and may reduce rates of antipsychotic use among long-term nursing home residents.

Keywords: Dementia, nursing home, antipsychotics, physical restraints, videoconferencing


Behavioral problems are some of the most frequent neuropsychiatric symptoms (NPS) of dementia.1 Although frequently seen in the nursing home setting, most nursing homes lack access to specialists, such as geriatric psychiatrists and behavioral neurologists with expertise in the management of these problems. This is in part because of a shortage of geriatricians and geropsychiatrists in the United States2 as well as the lack of proximity of many community nursing homes to tertiary care institutions where such specialists frequently work. As a result, caregivers may resort to physical or chemical restraints to manage behavior disorders among nursing home residents. Although there is little evidence to support the use of antipsychotic medications in such situations,36 more than 1 in 5 nursing home residents are prescribed antipsychotic medications without a supporting diagnosis.7 Further, antipsychotic medication use in nursing homes has been associated with increased risk of adverse events such as hip fractures and hospitalizations.8 Although physical restraint use has declined significantly over recent years, they are still occasionally used to manage disruptive behaviors, despite their established risks. They significantly compromise safety, dignity, and autonomy, and there is a growing body of evidence that they actually increase overall risk of falls and fracture as well as mortality.812

In 2012, clinicians at Beth Israel Deaconess Medical Center (BIDMC) in Boston launched Project ECHO-AGE, a biweekly, case-based video-consultation program aimed to extend relevant geriatric expertise in the care of patients with dementia to community-based nursing homes and thereby train frontline providers to become experts in dementia care. This model of care is based on the Extension for Community Healthcare Outcomes (ECHO) Project developed by Dr Sanjeev Aurora to successfully manage hepatitis C in rural New Mexico.1315

Our aim was to determine the impact of the ECHO-AGE intervention on the quality of care delivered to nursing home residents with dementia across participating facilities. In particular, we aimed to determine whether the intervention reduced physical and chemical restraint use.

Methods

An initial cohort of 16 nursing homes from Massachusetts and Maine was recruited to participate in ECHO-AGE. Of the initial facilities, 5 dropped out because of a lack of time or interest. Each of the facilities included in the final analysis presented at least 1 case and 1 follow-up case during the 18-month study period. Project ECHO-AGE uses secure, Health Insurance Portability and Accountability Act–compliant video-consultation technology to conduct a biweekly videoconference between teams of frontline nursing home staff and a team of clinical experts at BIDMC. Participants typically included a nurse and a certified nurse assistant, with an occasional nurse manager, activities director, or social worker. The clinical experts included a geriatrician facilitator, a geropsychiatrist who commented on psychoactive medications, a behavioral neurologist who interpreted cognitive tests and discussed the subtleties of treatment of dementia, and a part-time social worker who discussed behavioral modification plans. During each 120-minute biweekly session, participating nursing homes presented 3 to 4 challenging long-stay residents. A total of 115 cases were discussed during the study period. Didactic sessions were frequently included. Further details about the structure of the program, the issues discussed, and recommendations made, as well as a description of the qualitative findings from its first year, have been previously published.16 This research did not involve patient-level data and was deemed exempt by the BIDMC institutional review board.

Matching

Each of the 11 ECHO-AGE facilities was matched with 2 other similar facilities based on facility size (matched to within 32 beds, with 1 exception), for-profit status, region (using the New England City and Town Area designation [NECTA]), whether or not they were part of a larger nursing home chain, staff rating, and overall 5-star quality rating. Data from www.medicare.gov/NursingHomeCompare during the first 2 quarters of 2012 were used to identify staff and 5-star ratings.

Outcomes

Outcomes derived from the Minimum Data Set (MDS) 3.0 were obtained for each facility from www.medicare.gov/NursingHomeCompare. The MDS is a clinical assessment instrument that facilitates care management and payment schedules for nursing home residents, and is completed on all nursing home residents at the time of admission, quarterly thereafter, and with anyacute change in condition.17 Outcomes were collected only for long-stay residents, defined as a resident with 100 days or more in the same facility without 10 consecutive days outside the facility. Our primary outcomes were the percentage of long-stay residents who were physically restrained (item P0100, E-H in MDS 3.0) and who received an antipsychotic medication over the past 7 days (N0400A in MDS 3.0). A total of 9 other quality measures were collected as secondary outcomes, including percentage of long-stay residents with increased need for help with activities of daily living (ADLs), residents with self-reported moderate to severe pain, high-risk residents with pressure ulcers, residents who lose too much weight (loss of 5% or more of body weight in 1 month or 10% or more over 6 months), low-risk residents (as defined in the MDS manual) who lose control of bowel or bladder, residents in whom a catheter was inserted and left in their bladder, residents with a urinary tract infection, residents with depressive symptoms, and residents experiencing 1 or more falls with major injury.

Statistical Analysis

MDS data were downloaded for the 18-month period of the intervention and the preceding 4 quarters. Baseline quality measures were averaged across the 4 quarters preceding the intervention (Q2 2011 through Q1 2012). In addition to the MDS data, facility-level long-stay patient census data were obtained from the Center for Innovation in Quality at Brown University through a data use agreement. Means and SDs of the 11 quality measures of the nursing homes were calculated at baseline and at each of the 6 quarters of follow-up. Differences between intervention and control groups were tested using Student t test. We performed a logistic regression analysis to examine the relation between the intervention and each quality measure. We used generalized estimating equations to account for clustering within the matched sets and repeated measures over the 6 quarters. The quality measures (expressed as percentages within each facility) along with the patient census data were used to compute the number of residents with each outcome. Models were also adjusted for average baseline value of the quality measure. These same models were used to examine the changes in quality measures between baseline and the first quarter of the intervention, the period when the greatest changes were observed. Statistical analyses were performed using SAS version 9.4 (SAS Institute, Inc, Cary, NC).

Results

Baseline Characteristics

Of the 11 participating nursing homes, 8 were for-profit and 3 were nonprofit. The facilities in the intervention group had an average of 135 beds (62–355) versus 116 beds (46–186) in the control group. Baseline characteristics of the intervention and control groups were similar (Table 1).

Table 1.

Baseline Facility Characteristics

Measure Intervention
Control
n = 11 n = 22
Nursing home characteristics
Size, beds 135 (80.82) 116(36.47)
Range of beds (n) 62–355 46–186
Profit status, for-profit, n (%) 8 (73%) 16 (73%)
Chain status, yes, n (%) 10 (91%) 20 (91%)
% Medicaid 64.9 (28.5) 62.8 (23.6)
Staffing rating, 5-point scale 4 (0.4) 4 (0.4)
Quality measures (percentage of long-term care residents within past month)
Measure MDS No. Intervention
Control
P
n = 11 n = 22
Need for help with ADLs has increased 401 18.16 (4.37) 14.87 (5.52) .16
Self-report moderate to severe pain 402 9.16 (4.53) 8.97 (7.06) .36
High-risk residents with pressure ulcers 403 6.66 (4.07) 4.98 (2.06) .03
Lose too much weight 404 7.94 (2.08) 6.8 (2.75) .15
Low-risk residents who lose control of bowel or bladder 405 47.3 (11.17) 47.32 (15.26) .87
Catheter inserted and left in bladder 406 3.82 (2.01) 3.49 (2.75) .69
With urinary tract infection 407 6.85 (2.78) 7.85 (3.35) .55
With depressive symptoms 408 5.45 (6.42) 4.62 (4.25) .93
Were physically restrained 409 1.07 (1.45) 1.57 (2.29) .28
Experiencing 1 or more falls with major injury 410 3.6 (2.16) 3.68 (1.83) .97
Received an antipsychotic medication 419 25.99 (7.67) 27.9 (15.52) .53

MDS, Minimum Data Set; ADL, activities of daily living; SD, standard deviation.

Data are presented as mean (SD) unless otherwise stated.

At baseline, ECHO-AGE facilities reported that 26.0% of the residents had received an antipsychotic medication in the preceding month, versus 27.9% in the control group (P = .53). At baseline, 1.1% of long-stay residents in the intervention group had been physically restrained in the preceding month, versus 1.6% in the control group (P = .28). The only quality measure collected as a secondary outcome that showed a statistically significant difference between the intervention and control groups was percentage of high-risk residents with pressure ulcers. The intervention facilities had a higher percentage of these residents (P = .03).

In the adjusted logistic regression model, residents in ECHO-AGE facilities were 75% less likely to be physically restrained than residents in control facilities over the 18-month follow-up period (odds ratio [OR] = 0.25, P = .05). Additionally, residents in ECHO-AGE facilities were 17% less likely to be prescribed antipsychotic medication than residents in control facilities (OR = 0.83, P = .07). Of the secondary outcomes analyzed, residents in the ECHO-AGE facilities were 23% less likely to experience a urinary tract infection during the follow-up period (OR = 0.77, P = .01, Table 2).

Table 2.

Logistic Regression of Primary and Secondary Outcome Quality Measures

Outcome OR (95% Confidence Interval) for Intervention Effect P
Need for help with ADLs has increased 0.95 (0.77–1.19) .6684
Self-report moderate to severe pain 1.03 (0.72–1.48) .8655
High-risk residents with pressure ulcers 0.80 (0.60–1.07) .1322
Lose too much weight 1.20 (0.97–1.48) .0943
Low-risk residents who lose control of bowel or bladder 1.00 (0.76–1.32) .9986
Catheter inserted and left in bladder 0.89 (0.68–1.17) .4091
With urinary tract infection 0.77 (0.64–0.94) .0090
With depressive symptoms 1.09 (0.81–1.47) .5830
Were physically restrained 0.25 (0.06–1.04) .0574
Experiencing 1 or more falls with major injury 0.99 (0.78–1.27) .9629
Received an antipsychotic medication 0.83 (0.68–1.02) .0729

Model includes intervention + baseline.

For both of our primary outcomes, the greatest change occurred in the first quarter after the intervention began (2012 Quarter 3 [Q3]) (Figure 1). For physical restraints, the intervention group experienced a 67.3% decrease following initiation of the program (from an average of 1.1% to 0.4%), compared with an 11.5% increase in the control group (from an average of 1.6% to 1.8%) (OR = 0.58, P = .07). The decrease in the intervention group was maintained for the remaining 5 quarters. For antipsychotic use, the intervention group saw a 12.5% decrease in the quarter immediately following the start of the intervention (from an average of 26.0% to 22.7%), compared with a 4.2% increase in the control group (from an average of 27.9% to 29.1%) (OR = 0.95, P = .24). Antipsychotic use continued to gradually decline in the intervention group across the rest of the quarters. Based on the NH census data during the study, these percentages amounted to a reduction from 13 residents restrained at baseline to 4 residents restrained 3 months after the intervention began, compared with a change from 42 to 48 residents restrained in the control homes; and a reduction from 321 residents taking antipsychotics at baseline to 286 residents taking them 3 months after the intervention began, compared with a change from 668 to 677 taking antipsychotics in the control homes.

Fig. 1.

Fig. 1

Percentage of long-stay patients ordered for physical restraints and antipsychotics, by quarter, control versus intervention groups. Q, Quarter.

Discussion

In this prospective matched-cohort study, we evaluated a novel educational intervention that used videoconferencing technology to connect clinical experts at an academic medical center with frontline staff in community nursing homes to improve the care of residents with dementia and associated behavioral problems. We found preliminary evidence that this intervention was associated with a reduction in physical restraint use and a trend toward reduction in antipsychotic medication use among long-stay residents. Although national attention continues to reduce these potentially harmful treatments across the nursing home industry, the reduction experienced by the intervention group was in excess of that experienced by the matched controls. There is also no reason to believe that this “secular” trend affected the intervention group more than the control group. Given our modest sample size and the significant effect sizes observed, we believe this is a promising intervention worthy of further study.

There are several limitations to our study. First, its nonrandomized nature leaves open the potential for selection bias. Nursing homes that elected to participate in ECHO-AGE may be more strongly committed to quality improvement, better funded, or more generously staffed. Therefore, they may not be representative of a broader sample of facilities in Massachusetts, Maine, or other states. Second, as the facilities were aware we were studying the results, a Hawthorne effect is possible. Third, as a pilot study, the total number of facilities included was small and thus the study was underpowered to detect relatively small effect sizes. Fourth, given the low baseline rates of physical restraint use, it is possible that we are observing a floor effect rather than a meaningful reduction. Nevertheless, it is notable that physical restraint use did not increase while antipsychotic use decreased. Finally, we did not match on baseline rates of physical restraint and antipsychotic use. Given the other characteristics we matched on, it would have been relatively difficult to additionally match on baseline rates of the outcomes. Despite this, there were no differences in baseline rates between the intervention and control nursing homes and we did adjust all analyses for the baseline rates to account for any potential biases.

Our study used facility-wide data that was not limited to residents discussed in the ECHO-AGE conferences, which may have diluted the measured impact of the intervention. This was intentional, however, in that the goal of the intervention was to impact care across participating facilities. By using “long-stay” MDS data, we excluded residents recently readmitted from the hospital and all residents in assisted living, who were likely both positively impacted by the intervention. Also, our analysis may have underestimated the effect because changes in the dose or frequency of physical or chemical restraint use were not reflected. This is especially important given that research shows that significant factors in the overall mortality associated with antipsychotic medications are drug dosage, frequency, and duration.18,19

Despite its limitations, the study has several strengths, including its prospective design, 2:1 matching of controls, and repeated-measures analysis over time.

Conclusion

In this pilot study of a videoconference educational intervention focused on behavioral problems in nursing home residents with dementia, we found preliminary evidence of a reduction in use of physical restraints and a trend toward reduction in use of antipsychotic medications. The decrease in use of antipsychotics in particular, has implications for potentially decreasing costly adverse events such as falls, hip fractures, and hospitalizations. Given the importance of both of these measures in terms of the health, safety, and dignity of long-term care residents, further research on the potential of the ECHO intervention to improve the management of other geriatric conditions and ultimately reduce health care costs is warranted.

Acknowledgments

We appreciate the valuable assistance of Dr Sarah Berry for editing an early draft of the manuscript, Drs Vincent Mor and Julie Lima for advice on the statistical analysis, and Ms J. Elyse Krupp for her assistance with revisions. Nursing home census data were provided to us by the Brown University Center for Long-Term Care Quality and Innovation and covered under CMS Data Use Agreement 27716 “Post-Acute and Long-Term Care: Quality, Payment, and Accountability” (Principal Investigator Vincent Mor, funded by the American Health Care Association).

This study was funded by a grant from The Patrick and Catherine Weldon Donaghue Medical Research Foundation. Operational funding for Project ECHO-AGE comes from the Rx Foundation. S.E.G. received fellowship funding from the Hartford Foundation and the Health Services and Research Administration. L.A.L. holds the Irving and Edyth S. Usen and Family Chair in Geriatric Medicine at Hebrew SeniorLife, Boston, MA, and was supported by grants R01 AG041785 and R01 AG025037 from the National Institute on Aging and by grant P30 AG048785 from the Boston Roybal Center for Active Lifestyle Interventions. A.G.C. was supported by Academic Career Award KO1HP20494. The agencies that provided funding for the study had no role in the data collection, analysis, or writing of the article.

Footnotes

The authors declare no conflicts of interest.

References

  • 1.Selbaek G, Engedal K, Bergh S. The prevalence and course of neuropsychiatric symptoms in nursing home patients with dementia: A systematic review. J Am Med Dir Assoc. 2013;14:161–169. doi: 10.1016/j.jamda.2012.09.027. [DOI] [PubMed] [Google Scholar]
  • 2.Institute of Medicine . Retooling for an aging America: Building the health care workforce. The National Academics Press; Washington, DC: [August 3, 2015]. Available at: http://books.nap.edu/openbook.php?record_id=12089&page=R2; 2008. [Google Scholar]
  • 3.Lemay CA, Mazor KM, Field TS, et al. Knowledge of and perceived need for evidence-based education about antipsychotic medications among nursing home leadership and staff. J Am Med Dir Assoc. 2013;14:895–900. doi: 10.1016/j.jamda.2013.08.009. [DOI] [PubMed] [Google Scholar]
  • 4.Maher AR, Maglione M, Bagley S, et al. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: A systematic review and meta-analysis. JAMA. 2011;306:1359–1369. doi: 10.1001/jama.2011.1360. [DOI] [PubMed] [Google Scholar]
  • 5.Salzman C, Jeste DV, Meyer RE, et al. Elderly patients with dementia-related symptoms of severe agitation and aggression: Consensus statement on treatment options, clinical trials methodology, and policy. J Clin Psychiatry. 2008;69:889–898. doi: 10.4088/jcp.v69n0602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Voyer P, McCusker J, Cole MG, et al. Behavioral and psychological symptoms of dementia: How long does every behavior last, and are particular behaviors associated with PRN antipsychotic agent use? J Gerontol Nurs. 2015;41:22–37. doi: 10.3928/00989134-20141030-01. quiz 38-29. [DOI] [PubMed] [Google Scholar]
  • 7.Kuehn BM. Efforts stall to curb nursing home antipsychotic use. JAMA. 2013;310:1109–1110. doi: 10.1001/jama.2013.276603. [DOI] [PubMed] [Google Scholar]
  • 8.Chiu Y, Bero L, Hessol NA, et al. A literature review of clinical outcomes associated with antipsychotic medication use in North American nursing home residents. Health Policy. 2015;119:802–813. doi: 10.1016/j.healthpol.2015.02.014. [DOI] [PubMed] [Google Scholar]
  • 9.Bozat-Emre S, Doupe M, Kozyrskyj AL, et al. Atypical antipsychotic drug use and falls among nursing home residents in Winnipeg, Canada. Int J Geriatr Psychiatry. 2015;30:842–850. doi: 10.1002/gps.4223. [DOI] [PubMed] [Google Scholar]
  • 10.Lopez OL, Becker JT, Chang YF, et al. The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer’s disease. Am J Psychiatry. 2013;170:1051–1058. doi: 10.1176/appi.ajp.2013.12081046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Park Y, Franklin JM, Schneeweiss S, et al. Antipsychotics and mortality: Adjusting for mortality risk scores to address confounding by terminal illness. J Am Geriatr Soc. 2015;63:516–523. doi: 10.1111/jgs.13326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials. JAMA. 2005;294:1934–1943. doi: 10.1001/jama.294.15.1934. [DOI] [PubMed] [Google Scholar]
  • 13.Arora S, Geppert CM, Kalishman S, et al. Academic health center management of chronic diseases through knowledge networks: Project ECHO. Acad Med. 2007;82:154–160. doi: 10.1097/ACM.0b013e31802d8f68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Arora S, Kalishman S, Thornton K, et al. Expanding access to hepatitis C virus treatment—Extension for Community Healthcare Outcomes (ECHO) project: Disruptive innovation in specialty care. Hepatology. 2010;52:1124–1133. doi: 10.1002/hep.23802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Arora S, Thornton K, Jenkusky SM, et al. Project ECHO: Linking university specialists with rural and prison-based clinicians to improve care for people with chronic hepatitis C in New Mexico. Public Health Rep. 2007;122:74–77. doi: 10.1177/00333549071220S214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Catic AG, Mattison ML, Bakaev I, et al. ECHO-AGE: An innovative model of geriatric care for long-term care residents with dementia and behavioral issues. J Am Med Dir Assoc. 2014;15:938–942. doi: 10.1016/j.jamda.2014.08.014. [DOI] [PubMed] [Google Scholar]
  • 17.Morris JN, Hawes C, Fries BE, et al. Designing the national resident assessment instrument for nursing homes. Gerontologist. 1990;30:293–307. doi: 10.1093/geront/30.3.293. [DOI] [PubMed] [Google Scholar]
  • 18.Briesacher BA, Limcangco MR, Simoni-Wastila L, et al. The quality of antipsychotic drug prescribing in nursing homes. Arch Intern Med. 2005;165:1280–1285. doi: 10.1001/archinte.165.11.1280. [DOI] [PubMed] [Google Scholar]
  • 19.Simoni-Wastila L, Wei YJ, Luong M, et al. Quality of psychopharmacological medication use in nursing home residents. Res Social Adm Pharm. 2014;10:494–507. doi: 10.1016/j.sapharm.2013.10.003. [DOI] [PubMed] [Google Scholar]

RESOURCES